Rivelsa (Teva Pharmaceuticals USA, Inc.)
Welcome to the PulseAid listing for the Rivelsa drug offered from Teva Pharmaceuticals USA, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Pharmaceuticals USA, Inc. |
| NON-PROPRIETARY NAME: | Levonorgestrel/Ethinyl Estradiol and Ethinyl Estradiol |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2017-04-03 |
| END MARKETING DATE: | 0000-00-00 |
Rivelsa HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rivelsa from Teva Pharmaceuticals USA, Inc. |
| LABELER NAME: | Teva Pharmaceuticals USA, Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 2017-04-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0093-6031_7a4e7284-e5db-4f05-b666-7063395b3740 |
| PRODUCT NDC: | 0093-6031 |
| APPLICATION NUMBER: | NDA204061 |